AIM ImmunoTech Inc. (AIM) — 分析师展望 / 分析师共识目标价为. 基于 3 位分析师评级, 共识为 看涨 — 3 买入.
分析师预估 每股收益(EPS)为 $-29.97 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.31 vs 预期 $-29.97 (超预期 +99%). 2025: 实际 $-8.62 vs 预期 $-7.74 (不及预期 -11.3%). 分析师准确度: 0%.
AIM 分析师评级
Buy
基于过去3个月内 3 位分析师对 AIM ImmunoTech Inc. 的评级
EPS 预测 — AIM
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.31
vs Est –$29.97
▲ 9,567.8% off
2025
Actual –$8.62
vs Est –$7.74
▼ 10.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — AIM
84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 17.6% off
2025
Actual $0.000B
vs Est $0.000B
▼ 13.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
